Genmab — September 2019
-
“Tempus has built the world’s largest library of clinical and molecular data, is a leader in the field of personalized medicine and like Genmab, Tempus has a mission to improve the lives of cancer patients. We are looking forward to expanding our exciting partnership with them and to the possibility of discovering important new oncology targets and biomarkers,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.
Today’s news does not impact Genmab’s 2019 Financial Guidance.
-
Tempus' hjemmeside: https://www.tempus.com/
-
Og et lille skriv om firmaet fra maj i år: https://medcitynews.com/2019/05/chicago-precision-medicine-startup-tempus/
-
-
Og en nyhed udsendt i juni, hvor der snakkes rundtom hvervning af patienter til kliniske studier og om hvordan Tempus' kan hjælpe i den henseende: https://www.globenewswire.com/news-release/2019/06/03/1863365/0/en/Tempus-Announces-TIME-Trial-Service-a-New-Integrated-Molecular-Evaluation-that-Leverages-Artificial-Intelligence-to-Rapidly-Match-Cancer-Patients-to-Clinical-Trials.html
-
another JNJ duobody doubling anticipated recruitment (CD3 GPRC5D from 87 to 185 ) https://clinicaltrials.gov/ct2/history/NCT03399799?A=13&B=14&C=merged#StudyPageTop
-
Angående de 26 pts, der indgik i Enapotamab forsøget så skulle 4 pts være døde kort tid efter inclusion i forsøget og det skulle ikke være Enapotamab, der var årsag. Dernæst har 2 stk forladt forsøget af andre grunde. Det bringer klarhed om de 6 pts der var grupperet i “NE” og som indgår i procentberegningen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind